Key Takeaways From Agilon Health Analyst Ratings

In the preceding three months, 8 analysts have released ratings for Agilon Health AGL, presenting a wide array of perspectives from bullish to bearish.

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.

In the assessment of 12-month price targets, analysts unveil insights for Agilon Health, presenting an average target of $7.12, a high estimate of $9.00, and a low estimate of $5.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 32.19%.

Breaking Down Analyst Ratings: A Detailed Examination

The standing of Agilon Health among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Agilon Health. This offers insight into analysts' perspectives on the current state of the company.
• Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Agilon Health compared to the broader market.
• Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Agilon Health's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.

To gain a panoramic view of Agilon Health's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.

Stay up to date on Agilon Health analyst ratings.

Discovering Agilon Health: A Closer Look

Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.

Key Indicators: Agilon Health's Financial Health

Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.

Revenue Growth: Agilon Health displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately 120.54%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.

Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -28.26%, the company may need to address challenges in effective cost control.

Return on Equity (ROE): Agilon Health's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -30.04%, the company may face hurdles in generating optimal returns for shareholders.

Return on Assets (ROA): Agilon Health's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -11.47%, the company may face hurdles in achieving optimal financial returns.

Debt Management: With a below-average debt-to-equity ratio of 0.07, Agilon Health adopts a prudent financial strategy, indicating a balanced approach to debt management.

How Are Analyst Ratings Determined?

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

This article was generated by Benzinga's automated content engine and reviewed by an editor.